NCT01591044

Brief Summary

The purpose of this study is to determine the safety, efficacy and tolerability of R940343 in the treatment of mild to moderate asthma.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
301

participants targeted

Target at P75+ for phase_2 asthma

Timeline
Completed

Started Jul 2012

Geographic Reach
2 countries

59 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 3, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

September 29, 2016

Completed
Last Updated

September 29, 2016

Status Verified

August 1, 2016

Enrollment Period

1 year

First QC Date

April 30, 2012

Results QC Date

May 17, 2016

Last Update Submit

August 5, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in FEV1

    Change from baseline in pre-BD FEV1 (% predicted) at Week 8.

    Baseline and Week 8

Study Arms (3)

R940343 2mg, 2 puffs bid

ACTIVE COMPARATOR

R343 2mg, 2 puffs bid

Drug: R940343 2mg

Placebo

PLACEBO COMPARATOR
Drug: Placebo

R940343 1mg, 1 puff bid

ACTIVE COMPARATOR

R343 1mg, 1 puff bid

Drug: R940343 1mg

Interventions

1 puff bid or 2 puffs bid

Placebo

R343 1mg, 1 puff bid

Also known as: R343
R940343 1mg, 1 puff bid

R343 2mg, 2 puffs bid

Also known as: R343
R940343 2mg, 2 puffs bid

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical history of asthma
  • Ability to perform spirometry

You may not qualify if:

  • Chronic obstructive pulmonary disease or bronchiectasis
  • Upper or lower respiratory infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (59)

California Research Medical Group, Inc

Fullerton, California, 92835, United States

Location

Allergy Medical Clinic Research Division

Los Angeles, California, 90025, United States

Location

California Allergy & Asthma Medical Group, INC

Los Angeles, California, 90025, United States

Location

Southern California Institute for Respiratory Diseases, Inc.

Los Angeles, California, 90048, United States

Location

Allergy & Asthma Associates of Southern California

Mission Viejo, California, 92691, United States

Location

CHOC PSF, AMC, Division of Allergy, Asthma & Immunology

Orange, California, 92868, United States

Location

Peninsula Research Associates

Rolling Hills Estates, California, 90274, United States

Location

Allergy Associates Medical Group. Inc.

San Diego, California, 92120, United States

Location

Allergy & Asthma Med Group/Research Center

San Diego, California, 92123, United States

Location

Allergy & Asthma Associates of Santa Clara Valley

San Jose, California, 95117, United States

Location

Bensch Research Associates

Stockton, California, 95207, United States

Location

Colorado Allergy and Asthma Clinic, PC

Centennial, Colorado, 80112, United States

Location

Asthma & Allergy Associates, PC

Colorado Springs, Colorado, 80907, United States

Location

National Jewish Health

Denver, Colorado, 80206, United States

Location

Colorado Allergy & Asthma Centers, PC

Denver, Colorado, 80230, United States

Location

Florida Center for Allergy & Asthma Research

Aventura, Florida, 33180, United States

Location

Accelovance

Melbourne, Florida, 32935, United States

Location

Sarasota Clinical Research

Sarasota, Florida, 34233, United States

Location

Georgia Pollens Clinical Research Centers, Inc.

Albany, Georgia, 31707, United States

Location

Idaho Allergy DBA Idaho Research

Eagle, Idaho, 83616, United States

Location

Sneeze, Wheeze & Itch Associates

Normal, Illinois, 61761, United States

Location

Chesapeake Clinical Research, Inc.

Baltimore, Maryland, 21236, United States

Location

Northeast Medical Research Associates, Inc.

North Dartmouth, Massachusetts, 02747, United States

Location

Respiratory Medicine Researh Institute of Michigan

Ypsilanti, Michigan, 48197, United States

Location

Clinical Research Institute

Minneapolis, Minnesota, 55402, United States

Location

Clinical Research Institute, Inc.

Plymouth, Minnesota, 55441, United States

Location

Clinical Research of The Ozarks, Inc.

Columbia, Missouri, 65203, United States

Location

The Clinical Research Center, LLC

St Louis, Missouri, 63141, United States

Location

Clinical Research Group of Montana PLLC

Bozeman, Montana, 59718, United States

Location

The Asthma & Allergy Center

Bellevue, Nebraska, 68123, United States

Location

Atlantic Research Center, LLC

Ocean City, New Jersey, 07712, United States

Location

Princeton Center for Clinical Research

Skillman, New Jersey, 08558, United States

Location

Allergy Consultants, PA

Verona, New Jersey, 07044, United States

Location

New York Pulmonary Associates, P.C.

New York, New York, 10016, United States

Location

Allergy Asthma Immunology of Rochester (AAIR)

Rochester, New York, 14618, United States

Location

Peters Medical Research

High Point, North Carolina, 27262, United States

Location

North Carolina Clinical Research

Raleigh, North Carolina, 27607, United States

Location

New Horizons Clinical Research

Cincinnati, Ohio, 45242, United States

Location

Allergy, Asthma & Clinical Research Center

Oklahoma City, Oklahoma, 73120, United States

Location

Allergy & Asthma Research Group

Eugene, Oregon, 97401-7721, United States

Location

Clinical Research Inst. of Southern Oregon, PC

Medford, Oregon, 97504, United States

Location

Allergy Associates Research Center

Portland, Oregon, 97202, United States

Location

Allergy & Clinical Immunology Associates

Pittsburgh, Pennsylvania, 15241, United States

Location

National Allergy, Asthma and Uticaria Center of Charleston

Charleston, South Carolina, 29406, United States

Location

Pharmaceutical Research & Consulting, Inc.

Dallas, Texas, 75231, United States

Location

Western Sky Medical Research, Inc.

El Paso, Texas, 79903, United States

Location

Live Oak Allergy & Asthma Clinic

Live Oak, Texas, 78233, United States

Location

Allergy & Asthma Care of Waco, PA

Waco, Texas, 76712, United States

Location

Allergy Asthma Research Institute

Waco, Texas, 76712, United States

Location

ASTHMA, Inc.

Seattle, Washington, 98115, United States

Location

MultiCare Pulmonary Specialists

Tacoma, Washington, 98405, United States

Location

Joseph Greenbaum, MD

Hamilton, Ontario, L8N 1Y2, Canada

Location

Cheema Research, Inc.

Missassauga, Ontario, L5A 3V4, Canada

Location

Niagara Clinical Research

Niagara Falls, Ontario, L2G 1J4, Canada

Location

Ottawa Allergy Research Corp

Ottawa, Ontario, K1Y 4G2, Canada

Location

Pulmonary Care Clinic

Toronto, Ontario, M5G 1N8, Canada

Location

Primary Care Lung Clinic

Toronto, Ontario, M6H 3M2, Canada

Location

Dynamik Research, Inc.

Pointe-Claire, Quebec, H9R 3J1, Canada

Location

Centre De recherche Appliquee en Allergie DeQuebec

Québec, Quebec, G1V 4M6, Canada

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Results Point of Contact

Title
Anne-Marie Duliege, MD
Organization
Rigel

Study Officials

  • Elliott Grossbard, MD

    Rigel Pharmaceuticals,Inc.

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2012

First Posted

May 3, 2012

Study Start

July 1, 2012

Primary Completion

July 1, 2013

Study Completion

July 1, 2013

Last Updated

September 29, 2016

Results First Posted

September 29, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations